Sign in

CIK 0000093314

  • Non-accelerated filer
  • Smaller reporting company

VOLITIONRX LTD

Sign in to watch
Ticker
VNRX
Exchange
NYSE
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
911949078
Phone
+1 512-774-8930
Business address
1489 WEST WARM SPRINGS ROAD, SUITE 110, HENDERSON, NV, 89014
Former names
VOLITIONRX LTD, STANDARD CAPITAL CORP
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-08-15 Kway Jasmine CEO, Singapore Volition Grant or award +16,750 135,235
2024-08-15 Rootsaert Rodney Gerard Secretary Grant or award +11,000 121,336
2024-08-15 Butera Salvatore Thomas CEO, Volition Veterinary Grant or award +21,250 252,000
2024-08-15 Micallef Jacob Vincent Chief Scientific Officer Grant or award +13,750 312,974
2024-08-15 Reynolds Cameron John President and CEO Grant or award +29,500 1,874,350
2024-08-15 Colman Alan Director Grant or award +5,000 203,795
2024-08-15 Hughes Terig Chief Financial Officer Grant or award +19,500 350,076
2024-08-15 Henshall Mickie Director Grant or award +5,000 32,206
2024-08-15 Michel Gaetan Chief Operating Officer Grant or award +25,250 379,449
2024-07-04 Innes Guy Archibald Director Gift −400,000 251,683
2024-07-04 Innes Guy Archibald Director Gift +400,000 1,400,000
2024-06-01 Batchelor Ann-Louise Group Chief Marketing Officer Grant or award +11,685 86,299
2024-06-01 Colman Alan Director Grant or award +12,016 198,795
2024-06-01 Retter Andrew Chief Medical Officer Grant or award +8,326 108,326
2024-06-01 Reynolds Cameron John President and CEO Grant or award +90,182 1,844,850
2024-06-01 Forterre Gael Chief Commercial Officer Grant or award +8,944 137,120

Page 11 of 11 · 216 trades